Table 2.
Future liver remnant growth
| Procedure | FLR – pre (cc) | sFLR – pre (%) | FLR – post (cc) | sFLR – Post (%) | Time interval (days) | DH (%) | KGR (cc/d) | KGR (%/d) |
|---|---|---|---|---|---|---|---|---|
| ALPPS (n = 15) | 312.9 ± 84.7 | 20.1 ± 3.8 | 566.8 ± 147.6 | 36.1 ± 6.4 | 7.8 ± 1.1 | 84.3 ± 7.8 | 32.7 ± 13.6 | 10.8 ± 4.5 |
| PVE (n = 53) | 524.9 ± 219.5 | 31.4 ± 13.7 | 686.2 ± 250.8 | 41.0 ± 15.3 | 39.9 ± 14.2 | 36.0 ± 27.2 | 4.4 ± 3.2 | 0.98 ± 0.79 |
| LD (recip) (n = 90) | 968.2 ± 243.7 | 58.8 ± 11.7 | 1404.6 ± 279.8 | 86.1 ± 17.1 | 7.2 ± 1.0 | 49.2 ± 26.0 | 60.4 ± 28.9 | 6.8 ± 3.7 |
| LD (donor) (n = 93) | 479.9 ± 208.1 | 28.8 ± 9.4 | 946.1 ± 237.8 | 56.9 ± 9.2 | 6.9 ± 0.60 | 107.5 ± 39.2 | 67.9 ± 22.5 | 15.7 ± 5.9 |
cc, cubic centimetres; DH, degree hypertrophy; FLR, future liver remnant; KGH, kinetic growth rate; LD, living donor; PVE, portal vein embolization; sFLR, standardized future liver remnant.